Free public records show Nanoray Co., Ltd. in 1 of the markets we cover. It is not a key player in our research.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
2 510(k) clearances and PMA approvals since 2015
Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Retrieved 13 Nov 2026.
Markets we cover where free public records show Nanoray Co., Ltd.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Nanoray Co., Ltd. is in.
Stories on the topics Nanoray Co., Ltd. works in.
About 321,000 people were diagnosed with brain and nervous system tumours in 2022, and about 248,000 died…
Read
Oral diseases affect nearly 3.7 billion people. Most are preventable, but dental care is often left out of…
Read
Breast cancer is the most common cancer in women worldwide. Finding it early saves lives, but access to…
Read